Novo Nordisk - ADR

NVO

$91.13

+86.4% last 12 months

Jim Simons Holding value: $854 Million Ken Fisher Holding value: $694 Million Tom Gayner Holding value: $98 Million Tiger Global Holding value: $57.8 Million Ken Griffin Holding value: $19.9 Million Jefferies Group Holding value: $500 Thousand Steven Cohen Holding value: $6.11 Thousand John W. Rogers Jr. Holding value: $0 Ron Baron Holding value: $0 Polen Capital Holding value: $0 Jeremy Grantham Holding value: $0 Mario Gabelli Holding value: $0

Market Cap

$314 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$46.91 - $100.88

The lowest and highest price in the last 52 weeks.

Price-Earnings Ratio

0.0x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.03 (1.12%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Compare to
Market
Industry
Market Cap The market value of the company. It's calculated by multiplying the share price by the number of outstanding shares. $314 Billion
Enterprise Value A measure of a company's total value. This includes market cap, cash, and debt. -
Dividend Yield Yearly payout to shareholders per share. The percentage indicates the payout in relation to the share price. $1.03 (1.12%)
1 Year Return Profit or loss of share price change plus dividend yield. +87.5%
52-Week High Highest share price in the last 52 weeks. $100.88
52-Week Low Lowest share price in the last 52 weeks. $46.91
Beta Beta indicates the volatility of a stock compared to the market. Higher beta means more volatile and thus potentially higher risk and return. 0.34
Outstanding Shares The number of shares the company has issued and are held by stockholders. 3.44 Billion
Avg 30 Day Volume The number of shares traded in the last 30 days. 4.43 Million

Valuation

Compare to
Market
Industry
P/E Ratio Ratio between share price and earnings per share. A low ratio could indicate that the stock is undervalued or investors aren't expecting high growth. A high ratio could indicate that the stock is overvalued or investors are expecting high growth. -
PEG The ratio between the P/E ratio and the growth rate of the company's earnings per share in the last twelve months. A lower PEG could mean that a stock is undervalued. -
Earnings per Share Earnings divided by outstanding shares. Higher EPS indicates greater value. $0.00
Price to Sales Ratio Market cap divided by the revenue in the most recent year. -
Price to Book Ratio Price to Book Ratio is the Market cap divided by the Book value of the company -
Enterprise Value to Revenue Enterprise value divided by revenue -
Enterprise Value to EBIT Enterprise Value divided by EBIT -
Total Debt to Enterprise Value Total debt divided by enterprise value -
Debt to Equity A higher ratio indicates a higher risk. However, the ratio is difficult to compare between industries where common amounts of debt vary. -

Profitability

Compare to
Market
Industry
Revenue Revenue is the sum of all cash flow into the company. -
Gross Profit Gross profit is the profit after subtracting the costs of making and selling its products or the costs of providing its services. It indicates the efficiency of using their resources to produce goods or services. -
EBIT Earnings before tax and interest payments. -
Net Income Net Income is the profit after all expenses have been deducted from the total revenue. -
Profit Margin Net income divided by revenue of the last 4 quarters. It indicates the company's profitability. -
Quarterly Earnings Growth (YoY) The rate at which the company's net income has increased to the same quarter one year ago. -
Return on Equity Equity divided by market cap. -
Return on Assets Indicates a company's profitability in relation to its total assets. -
Return on Invested Capital Return on invested capital (ROIC) is net income after dividends divided by the sum of debt and equity. It shows how effective a company is at turning capital invested by shareholders and other debtholders into profits. -

Insider trades

No purchases

No sells

No purchases

No sells

No purchases

No sells

No purchases

No sells

Q4 2022 Q1 2023 Q2 2023 Q3 2023

About Novo Nordisk - ADR

CEO: Lars Fruergaard Joergensen

Industry: Medicinal and Botanical Manufacturing

Similar stocks

Pfizer Inc.
Pfizer Inc.
Lilly(Eli) & Co
Lilly(Eli) & Co
Sanofi - ADR
Sanofi - ADR

News

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases

Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases

Novo Nordisk A/S and Valo Health, Inc. announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases ba...

Science|Business Science|Business, about 6 hours ago
Which High-Profile Stock-Split Stock Is the Cheapest? Get Ready to Be Shocked...

Which High-Profile Stock-Split Stock Is the Cheapest? Get Ready to Be Shocked...

Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk, there''s one clear-cut stock-split stock that...

The Motley Fool The Motley Fool, 1 day ago
WW International Shares Jump On BCBS Michigan''s Revised Authorization For Wegovy, Other Weight Loss Drugs

WW International Shares Jump On BCBS Michigan''s Revised Authorization For Wegovy, Other Weight Loss Drugs

Shares of WW International Inc (NASDAQ: WW ) spiked as much as 15% on Friday after Blue Cross Blue Shield of Michigan and Blue Care Network announced changes...

Benzinga Benzinga, 4 days ago
South Africa: Aspen''s Novo Nordisk Deal a ''Feather in Our Cap'' and an NCD Battle Boost - Top Executive

South Africa: Aspen''s Novo Nordisk Deal a ''Feather in Our Cap'' and an NCD Battle Boost - Top Executive

[Daily Maverick] The success of the Danish company - Europe''s second most valuable - is largely built on its weight-loss drugs.

All Africa Global Media All Africa Global Media, 4 days ago
Never miss a trade
To improve your user experience we use cookies.